Free Trial
OTCMKTS:PCHM

PharmChem Q3 2023 Earnings Report

$3.90 0.00 (0.00%)
As of 07/11/2025

PharmChem EPS Results

Actual EPS
$0.04
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

PharmChem Revenue Results

Actual Revenue
$1.56 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

PharmChem Announcement Details

Quarter
Q3 2023
Time
N/A
Conference Call Date
Thursday, November 2, 2023
Conference Call Time
11:00AM ET

Upcoming Earnings

PharmChem's next earnings date is estimated for Tuesday, August 5, 2025, based on past reporting schedules.

Earnings Documents

PharmChem Earnings Headlines

PharmChem, Inc. (PCHM) - Yahoo Finance
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
PharmChem considers strategic alternatives
See More PharmChem Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PharmChem? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PharmChem and other key companies, straight to your email.

About PharmChem

PharmChem (OTCMKTS:PCHM) (OTCMKTS:PCHM) is a specialty chemical company focused on the development, manufacturing and distribution of preservatives, antioxidants and related performance additives for the personal care, pharmaceutical, and industrial markets. Since its founding in the mid-1990s as a standalone supplier, PharmChem has built a reputation for high-purity, regulatory-compliant ingredients that help formulators extend shelf life, improve stability and meet evolving global safety standards.

The company’s product portfolio includes a broad range of antimicrobial preservatives—such as DMDM hydantoin alternatives, organic acids and blends—alongside primary and secondary antioxidants designed for everything from cosmetic creams to pharmaceutical dosage forms. In addition to off-the-shelf solutions, PharmChem offers custom blending and formulation services, leveraging its in-house laboratories and application testing to address specific client performance and regulatory requirements.

Headquartered in Jacksonville, Florida, PharmChem maintains manufacturing and research facilities in the United States, with distribution partners across Europe and Asia to serve a global customer base. The company’s logistics network and regulatory support teams help multinational customers navigate complex regional registration processes, ensuring timely product launches and compliance with local and international standards.

Under the leadership of an executive team with decades of industry experience, PharmChem emphasizes innovation, quality control and sustainable practices. The company continually invests in R&D and works closely with strategic partners to develop next-generation preservatives and antioxidants, positioning itself as a responsive, science-driven supplier in the evolving specialty chemicals landscape.

View PharmChem Profile

More Earnings Resources from MarketBeat